# FDA Inspection 848922 - Vitalant - September 18, 2013

Source: https://www.keypedia.com/records/fda_inspections/vitalant/e5ccbc36-9dd3-44a6-bdb6-c439a6be404d
Source feed: FDA_Inspections

> FDA Inspection 848922 for Vitalant on September 18, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 848922
- Company Name: Vitalant
- Inspection Date: 2013-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1115247 - 2019-11-05](https://www.keypedia.com/records/fda_inspections/vitalant/78687647-01d1-4f7e-b41f-ddef81468ce2)
- [FDA Inspection 1115247 - 2019-11-05](https://www.keypedia.com/records/fda_inspections/vitalant/4e7ebaad-d1e0-40fe-a549-63a4d1ad2067)
- [FDA Inspection 1049590 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/vitalant/7cd017a7-8c44-46cd-8460-f2166bd4a8de)
- [FDA Inspection 986765 - 2016-09-14](https://www.keypedia.com/records/fda_inspections/vitalant/00341cc0-042d-4bc4-89bc-f0736ba9166d)
- [FDA Inspection 743495 - 2011-08-26](https://www.keypedia.com/records/fda_inspections/vitalant/cf69eede-8557-4d66-b06b-dc85a203534f)

Company: https://www.keypedia.com/companies/vitalant/2f2a5f9b-61b0-4e3b-8295-ebc9f010abc8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d